Should venom AIT be stopped during the COVID-19 pandemic?
AIT should continue in non-infected patients or those recovered from COVID-19. This is especially important in patients with life-threatening conditions such as venom allergy. It is possible to extend the intervals between vaccines during subcutaneous AIT, as done for inhalant allergens, to minimize visits to the allergy clinic. If venom AIT was stopped due to SARS-CoV-2 infection, it is unclear when it should be re-initiated because data from convalescent patients is scarce.118